Literature DB >> 22492221

Serum anti-müllerian hormone, follicle stimulating hormone and antral follicle count measurement cannot predict pregnancy rates in IVF/ICSI cycles.

Sezai Sahmay1, Gökhan Demirayak, Onur Guralp, Pelin Ocal, Levent M Senturk, Engin Oral, Tulay Irez.   

Abstract

PURPOSE: To investigate whether serum anti-müllerian hormone (AMH), follicle stimulating hormone (FSH), or antral follicle count (AFC) are predictive for clinical pregnancy in in vitro fertilization (IVF) patients.
METHODS: Serum AMH, inhibin B, FSH, luteinizing hormone (LH), estradiol (E2), prolactin, and thyroid stimulating hormone (TSH) levels and AFC of 189 women under 40 years of age were investigated. Pregnant and non-pregnant women were compared.
RESULTS: Forty-seven (24.8 %) clinical pregnancies were observed in 189 women. There was no significant difference in terms of mean age, duration of infertility, body mass index, AMH, LH, FSH, E2, TSH, Inhibin B, AFC and total oocyte number between women who did and who did not become pregnant. Additionally, there was no significant difference in clinical pregnancy rates between the quartiles of AMH, FSH and AFC. (P values were 0.668, 0.071, and 0.252, respectively.)
CONCLUSION: Serum AMH and FSH, and AFC cannot predict clinical pregnancy in IVF patients under 40; the pregnancy rate tends to increase as AMH increases, although this remains non-significant.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22492221      PMCID: PMC3401265          DOI: 10.1007/s10815-012-9754-6

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.412


  32 in total

1.  Serum anti-Müllerian hormone is more strongly related to ovarian follicular status than serum inhibin B, estradiol, FSH and LH on day 3.

Authors:  Renato Fanchin; Luca Maria Schonäuer; Claudia Righini; Jean Guibourdenche; René Frydman; Joëlle Taieb
Journal:  Hum Reprod       Date:  2003-02       Impact factor: 6.918

2.  Basal follicle-stimulating hormone level is a better predictor of in vitro fertilization performance than age.

Authors:  J P Toner; C B Philput; G S Jones; S J Muasher
Journal:  Fertil Steril       Date:  1991-04       Impact factor: 7.329

3.  Serum anti-Müllerian hormone and antral follicle count as predictive markers of OHSS in ART cycles.

Authors:  Pelin Ocal; Sezai Sahmay; Meral Cetin; Tulay Irez; Onur Guralp; Ismail Cepni
Journal:  J Assist Reprod Genet       Date:  2011-09-01       Impact factor: 3.412

4.  Day 3 serum inhibin-B is predictive of assisted reproductive technologies outcome.

Authors:  D B Seifer; G Lambert-Messerlian; J W Hogan; A C Gardiner; A S Blazar; C A Berk
Journal:  Fertil Steril       Date:  1997-01       Impact factor: 7.329

5.  Anti-Müllerian hormone attenuates the effects of FSH on follicle development in the mouse ovary.

Authors:  A L Durlinger; M J Gruijters; P Kramer; B Karels; T R Kumar; M M Matzuk; U M Rose; F H de Jong; J T Uilenbroek; J A Grootegoed; A P Themmen
Journal:  Endocrinology       Date:  2001-11       Impact factor: 4.736

6.  Anti-müllerian hormone and anti-müllerian hormone type II receptor messenger ribonucleic acid expression in rat ovaries during postnatal development, the estrous cycle, and gonadotropin-induced follicle growth.

Authors:  W M Baarends; J T Uilenbroek; P Kramer; J W Hoogerbrugge; E C van Leeuwen; A P Themmen; J A Grootegoed
Journal:  Endocrinology       Date:  1995-11       Impact factor: 4.736

7.  Follicle-stimulating hormone levels on cycle day 3 are predictive of in vitro fertilization outcome.

Authors:  R T Scott; J P Toner; S J Muasher; S Oehninger; S Robinson; Z Rosenwaks
Journal:  Fertil Steril       Date:  1989-04       Impact factor: 7.329

8.  Anti-Müllerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment.

Authors:  Christien Weenen; Joop S E Laven; Anne R M Von Bergh; Mark Cranfield; Nigel P Groome; Jenny A Visser; Piet Kramer; Bart C J M Fauser; Axel P N Themmen
Journal:  Mol Hum Reprod       Date:  2004-02       Impact factor: 4.025

9.  A mathematical model of follicle dynamics in the human ovary.

Authors:  M J Faddy; R G Gosden
Journal:  Hum Reprod       Date:  1995-04       Impact factor: 6.918

Review 10.  [Inhibins, activins and anti-Müllerian hormone: structure, signalling pathways, roles and predictive value in reproductive medicine].

Authors:  X Deffieux; J-M Antoine
Journal:  Gynecol Obstet Fertil       Date:  2003-11
View more
  6 in total

1.  The role of serum AMH and FF AMH in predicting pregnancy outcome in the fresh cycle of IVF/ICSI: a meta-analysis.

Authors:  Lingnv Yao; Wei Zhang; Hong Li; Wenqin Lin
Journal:  Int J Clin Exp Med       Date:  2015-02-15

2.  Anti-müllerian hormone levels as a predictor of the pregnancy rate in women of advanced reproductive age.

Authors:  Sezai Sahmay; Mahmut Oncul; Abdullah Tuten; Abdullah Tok; Abdullah Serdar Acıkgoz; Ismail Cepni
Journal:  J Assist Reprod Genet       Date:  2014-09-04       Impact factor: 3.412

3.  Diagnosis of Polycystic Ovary Syndrome: AMH in combination with clinical symptoms.

Authors:  Sezai Sahmay; Yavuz Aydin; Mahmut Oncul; Levent M Senturk
Journal:  J Assist Reprod Genet       Date:  2013-12-18       Impact factor: 3.412

4.  β-Edorphin predict pregnancy outcome of PCOS and DOR women after IVF-ET.

Authors:  Chan Zhang; Shengxian Liu; Gelin Liu; Yuhui He; Yanan Wang; Fang Wang
Journal:  Arch Gynecol Obstet       Date:  2020-11-28       Impact factor: 2.344

5.  Predicting the outcome of different protocols of in vitro fertilization with anti-Muüllerian hormone levels in patients with polycystic ovary syndrome.

Authors:  Ya Chen; Bilv Ye; Xiaojing Yang; Jiujia Zheng; Jinju Lin; Junzhao Zhao
Journal:  J Int Med Res       Date:  2017-04-28       Impact factor: 1.671

6.  Serum anti-Müllerian hormone levels are associated with early miscarriage in the IVF/ICSI fresh cycle.

Authors:  Xin Liu; Ying Han; Xinyan Wang; Yunshan Zhang; Aijun Du; Ruqiang Yao; Jiabei Lv; Haining Luo
Journal:  BMC Pregnancy Childbirth       Date:  2022-04-02       Impact factor: 3.105

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.